Invicta Diagnostic IPO
Invicta Diagnostic is an NSE SME IPO listed on the NSE SME platform, priced at ₹80–₹85 per share. The stock debuted at ₹100, delivering a listing gain of 17.6%. The IPO had a lot size of ₹1600 shares and a minimum investment of ₹2,72,000.
Invicta Diagnostic Limited IPO
- IPO Dates
- Dec 1, 2025 – Dec 3, 2025
- Price band
- ₹80-85 per equity share
- Minimum Investment
- ₹2,72,000
- Issue size
- ₹28.12 Cr
- Lot size
- 1600
- Allotment Date
- Dec 4, 2025
- Listing
- Dec 8, 2025
- Listing At
- NSE SME
IPO timeline
-
Dec 1, 2025
Open Date
Completed
-
Dec 3, 2025
Close Date
Completed
-
Dec 4, 2025
Allotment Date
Completed
-
Dec 8, 2025
Listing Date
Completed
Invicta Diagnostic IPO Subscription Details
View Subscription DetailsInvicta Diagnostic IPO subscription status shows demand across QIB, NII, and retail categories, helping investors understand participation levels.
Last updated:Invicta Diagnostic IPO Essentials
Invicta Diagnostic IPO Details
Invicta Diagnostic IPO is priced at ₹80-85 per share with a total issue size of 28.12 crore. The IPO has a lot size of 1600 shares and is listed on NSE SME.
- Issue price
- ₹80-85 per equity share
- Lot size
- 1600 shares
- Face value
- ₹10 Per Equity Share
- Issue size
- 33,08,800 shares(aggregating up to ₹28.12 Cr)
- Total issue size
- 33,08,800 shares
(aggregating up to ₹28.12 crore) - Fresh issue
- 33,08,800 shares
(aggregating up to ₹28.12 crore) - Listing at
- NSE SME
- List price
- 100.0
- Listing date
- Registrar
- Bigshare Services Pvt Ltd
- Lead manager
-
Socradamus Capital Pvt Ltd
Market Lot Size
Investors can bid for a minimum of 3200 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual (min) | 2 | 3200 | ₹2,72,000 |
| Individual(max) | 2 | 3200 | ₹2,72,000 |
| sHNI(min) | 3 | 4800 | ₹4,08,000 |
| sHNI(max) | 7 | 11,200 | ₹9,52,000 |
| sHNI(min) | 8 | 12,800 | ₹10,88,000 |
Invicta Diagnostic IPO Reservation
Invicta Diagnostic IPO reservation details show category-wise allocation of shares. Out of the total 3308800 shares, approximately 16.15% are reserved for QIB, 16.39% for NII, 38.3% for retail investors, 5.03% for market maker, and 24.13% for anchor investors.
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | 798400 (24.13%) | |
| Market Maker Shares Offered | 166400 (5.03%) | |
| QIB Shares Offered | 534400 (16.15%) | |
| NII (HNI) Shares Offered | 542400 (16.39%) | |
| bHNI > ₹10L | 361600 (9.39%) | 75 |
| sHNI < ₹10L | 180800 (4.85%) | 38 |
| Individual Shares Offered | 1267200 (38.3%) | 396 |
| Total Shares Offered | 3308800 (100%) |
Invicta Diagnostic IPO Analytics
Invicta Diagnostic IPO category-wise subscription trends show day-wise participation across QIB, NII, and retail investors.
Invicta Diagnostic IPO Subscription Status
Invicta Diagnostic IPO subscription status shows demand across retail, NII, and QIB categories, helping investors understand overall participation trends.
The IPO is currently subscribed 4.34x, indicating moderate demand across investor categories.
| As on | QIB |
NII
bHNI
sHNI
|
Individual | Total |
|---|---|---|---|---|
| Shares Offered / Reserved | 5,34,400 |
5,42,400
3,61,600
1,80,800
|
12,67,200 | 23,44,000 |
|
Day 1
01-12-25 05:00 PM
|
1.00 x |
0.68x
0.79x
0.45x
|
0.28 x | 0.54 x |
|
Day 2
02-12-25 05:00 PM
|
1.55 x |
1.04x
1.27x
0.58x
|
0.79 x | 1.02 x |
|
Day 3
03-12-25 05:00 PM
|
3.51 x |
7.27x
7.76x
6.27x
|
3.44 x | 4.34 x |
|
Total No. of Applications
|
bHNI | sHNI | Individual |
|---|---|---|---|
| 1772 (Approx) | 2.52x | 5.74x | 3.44x |
Invicta Diagnostic Valuations
Earnings
- EPS Pre IPO
- ₹5.86/-
- EPS Post IPO
- ₹6.50/-
- P/E Pre IPO
- 14.51
- P/E Post IPO
- 13.08
Returns
- ROE
- 44.28%
- ROCE
- 42.00%
- RoNW
- 36.25%
- PAT Margin
- 16.38%
Fundamentals
- Debt / Equity
- 0.26
- Price / Book
- 5.26
- Market Cap
- 106.86 Cr.
Invicta Diagnostic Financials( In Crs.)
| 30-Sep-25 | 31-Mar-25 | 31-Mar-24 | |
|---|---|---|---|
| Assets | 34.90 | 21.22 | 15.89 |
| Revenue | 17.08 | 30.18 | 15.90 |
| Profit After Tax | 4.08 | 4.93 | 3.81 |
| Net Worth | 23.68 | 13.60 | 8.67 |
| Reserves & Surplus | 14.42 | 5.18 | 8.54 |
| Total Borrowing | 3.72 | 3.54 | 3.81 |
Invicta Diagnostic Company & Offer Insights
About Invicta Diagnostic
Incorporated in January 2021, Invicta Diagnostic Limited offers radiology and pathology solutions. It provides pathology and radiology testing comprising imaging, radiology, pathology, and teleradiology services under the brand 'PC Diagnostics” through 7 diagnostic centres and a central laboratory across Mumbai in Maharashtra.
Invicta Diagnostics Limited, trading as PC Diagnostics, is a Mumbai-based diagnostic services company specializing in integrated pathology and radiology solutions. The company follows a hub‑and‑spoke model across the Mumbai Metropolitan Region, featuring:
A flagship hub offering full-spectrum pathology and advanced radiology (CT, MRI) at Thane West
Three other centres - Bhayandar, Byculla, Marol - offering specialized diagnostic services
Basic imaging, including X-ray and ultrasound, and sample collection were the focus of spokes at Lower Parel, Sewri, Mazgaon, and Kalwa.
It offers approximately 60 routine and 487 specialized pathology tests and around 96 basic and 130 advanced radiology investigations.
Invicta Diagnostics provides a comprehensive suite of diagnostic services that includes:
Routine Tests: Includes CBC, lipid profiles, liver function tests (LFT), kidney function tests (KFT), and thyroid panels
Specialized Tests: Molecular diagnostics, immunoassays, infectious disease markers including dengue, COVID-19, cancer markers, and genetic panels.
Sample Collection Network: Invicta uses phlebotomists and collection partners to reach patients at home or through its spoke centres. The company has a network of 5 laboratory doctors, 20 radiologists, and 127 well-trained technical staff as of May 31st, 2025. The company has 105 permanent employees as of May 31, 2025.
Invicta Diagnostic Promoter(s)
Dr. Ketan Jayantilal Jain, Dr. Sanket Vinod Jain, Rohit Prakash Srivastava, Badal Kailash Naredi, Jayesh Prakash Jain are the company's promoters of Invicta Diagnostic.
Invicta Diagnostic IPO Issue Objectives
- •
- Funding capital expenditure for purchase of medical equipment towards establishment of five new diagnostic centres in Maharashtra
- •
- General Corporate purposes
Contact Information
Contact Details
Invicta Diagnostic
022-4971-0036
1 GF, Plot 217, Ambavat Bhavan, N.M Joshi Marg, Delisle Road, Mumbai, Maharashtra, 400013
Registrar Contact Details
Bigshare Services Pvt Ltd
+91-22-6263 8200
Frequently Asked Questions
Click any question to reveal the answer
Invicta Diagnostic IPO is a book-built IPO worth ₹28.12 crore. The price band is ₹80–₹85 per share. The IPO opens on Dec 1, 2025 and closes on Dec 3, 2025. It will be listed on NSE SME Platform. Bigshare Services Pvt Ltd is the registrar.
The price band of Invicta Diagnostic IPO is ₹80 to ₹85 per share.
The lot size of Invicta Diagnostic IPO is 1600 shares.
The minimum investment for Invicta Diagnostic IPO is approximately ₹2,72,000 based on the upper price band .
Invicta Diagnostic IPO opens on Dec 1, 2025 and closes on Dec 3, 2025.
The allotment date of Invicta Diagnostic IPO is Dec 4, 2025.
Invicta Diagnostic IPO is expected to be listed on Dec 8, 2025, on NSE SME Platform.
Invicta Diagnostic IPO valuation snapshot: P/E 13.08, EPS ₹6.50/-, P/B 5.26, RoNW 36.25%, and market cap 106.86 Cr.
To apply for Invicta Diagnostic IPO, open the IPO Ji app or website, select the IPO, choose your demat account, enter the quantity, and submit the application.
You can check the live subscription status of Invicta Diagnostic IPO on IPO Ji or stock exchange websites. It shows real-time demand across retail, NII, and QIB categories.
Pre-apply allows investors to submit their IPO application before the bidding period starts. The order is placed automatically when the IPO opens.
If you pre-apply for Invicta Diagnostic IPO, your order will be placed when the IPO bidding starts, and a UPI mandate request will be generated.
You can check Invicta Diagnostic IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Invicta Diagnostic IPO allotment status on IPO Ji for quick and easy access.